Delivery Order SPE2DB24D2205-SPE2DB25FEBTX

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,112.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $23,710.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain medical conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $9,483.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Otezla 30 mg tablets in 60-count packaging. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,341.67 firm fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. This award is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $56,208.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Otezla 30 mg tablets, a medication used for various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,649.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $25,872.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Otezla 30 mg tablets, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $11,306.46, is for the delivery of Otezla 30 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing...
This federal contract award is a delivery order valued at $12,752.07 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4559428588 - OTEZLA 30 MG TABLET 60S, a specialty medication. The award has a firm fixed price pricing type and an ultimate completion date of December 21, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,381.59 firm fixed-price delivery order is for Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBTX
    Delivery Order

This federal contract award, valued at $25,094.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/31/25, 10:29 AM